XML 25 R8.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Organization, Nature of Operations and Basis of Presentation | 12 Months Ended
--- | ---
Dec. 31, 2024
Organization, Nature of Operations and Basis of Presentation [Abstract] |
Organization, Nature of Operations and Basis of Presentation | 1. Organization, Nature of Operations and Basis of Presentation The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc., its subsidiaries, and variable interest entities for which the Company has determined it is the primary beneficiary (the “Company”). All significant intercompany transactions and balances have been eliminated. The Company operates its business through two reportable business segments. The Company’s reportable segments include the physical therapy operations segment and the industrial injury prevention services (“IIP”) segment. The Company’s physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by the IIP segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. During the last three years, the Company completed the acquisitions of the following clinic practices and IIP businesses detailed below:
|  |  |  | % Interest |  | Number of
Acquisition |  | Date |  | Acquired |  | Clinics
November 2024 Acquisition |  | November 30, 2024 |  | 75% |  | 8
October 2024 Acquisition |  | October 31, 2024 |  | 50% |  | 50
August 2024 Acquisition |  | August 31, 2024 |  | 70% |  | 8
April 2024 Acquisition |  | April 30, 2024 |  | ** |  | *
March 2024 Acquisition |  | March 29, 2024 |  | 50% |  | 9
October 2023 Acquisition |  | October 31, 2023 |  | *** |  | *
September 2023 Acquisition 1 |  | September 29, 2023 |  | 70% |  | 4
September 2023 Acquisition 2 |  | September 29, 2023 |  | 70% |  | 1
July 2023 Acquisition |  | July 31, 2023 |  | 70% |  | 7
May 2023 Acquisition |  | May 31, 2023 |  | 45% |  | 4
February 2023 Acquisition |  | February 28, 2023 |  | 80% |  | 1
November 2022 Acquisition |  | November 30, 2022 |  | 80% |  | 13
October 2022 Acquisition |  | October 31, 2022 |  | 60% |  | 14
September 2022 Acquisition |  | September 30, 2022 |  | 80% |  | 2
August 2022 Acquisition |  | August 31, 2022 |  | 70% |  | 6
March 2022 Acquisition |  | March 31, 2022 |  | 70% |  | 6
* | IIP business.
** | On April 30, 2024, one of our IIP businesses, Briotix Health Limited Partnership, acquired 100% of an IIP business.
*** | On October 31, 2023, we concurrently acquired 100% of an IIP business and a 55% equity interest in an ergonomics software business.
Besides the multi-clinic acquisitions referenced in the table above, during 2024 and 2023, the Company purchased the assets and businesses of eight and nine physical therapy clinics, respectively, in separate transactions. In May 2023, the Company completed a secondary offering of 1,916,667 shares of its common stock at an offering price of $90.00 per share. Upon completion of the offering, the Company received net proceeds of approximately $163.6 million, after deducting an underwriting discount of $8.6 million and recognizing related fees and expenses of $0.2 million. A portion of the net proceeds was used to repay the $35.0 million then outstanding under the Company’s credit facility while the remainder was used primarily for additional acquisitions.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/810/tableOfContent Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/205/tableOfContent + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration